HSG

HSG is a venture capital and private equity firm founded in 2005, formerly known as Sequoia Capital China, managing over USD 55 billion. It invests globally from seed through later-stage venture and other private-market strategies across technology, healthcare and consumer sectors. Venture activity spans biotechnology, life sciences, medical devices, oncology, AI, robotics, fintech, payments and blockchain across China, the United States, Singapore, Hong Kong and France, and the firm has acted as a lead investor. Offices include Hong Kong, Shanghai, Beijing, Shenzhen, Singapore, London and Tokyo.